Trial intelligence / Profile preview

Sculptra and Sofwave for Upper Arm Skin Aging

NCT07342452Phase 4Not yet recruiting

Sponsor
Massachusetts General Hospital
Start
Jan 2027
Primary completion
Apr 2027
Modality
Polymer-based Nanoparticles, Device-based Delivery
Countries
1
01

Overview

A Phase 4 trial of poly(L-lactic acid) in Skin aging, sponsored by Massachusetts General Hospital. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

poly(L-lactic acid)
03

Conditions

Skin aging

Beyond the preview

Go deeper on NCT07342452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07342452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call